Tetrac is a thyroid hormone antagonist at the thyroid hormone-tetrac receptor on cell surface integrin αvβ3 and exposure of tumor cells to tetrac desirably increases retention time of the cancer chemotherapeutic agents that are known substrates of P-gp. The gene discussed is TG; the disease is neoplasm.